Top Page
Lifeway Foods
(NASDAQ:LWAY)
Lifeway Foods (LWAY) vs. SPDR S&P 500 ETF (SPY)
Lifeway Foods Business Overview & Revenue Model
Lifeway Foods Earnings Call Summary
Lifeway Foods Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 204.07M | 186.82M | 160.12M | 141.57M | 119.06M | 102.03M |
| Gross Profit | 55.65M | 48.57M | 42.44M | 26.79M | 28.71M | 26.93M |
| EBITDA | 20.66M | 17.46M | 20.20M | 5.08M | 8.61M | 8.19M |
| Net Income | 11.16M | 9.03M | 11.37M | 924.00K | 3.31M | 3.23M |
Balance Sheet | ||||||
| Total Assets | 109.53M | 90.55M | 82.64M | 69.00M | 71.55M | 62.05M |
| Cash, Cash Equivalents and Short-Term Investments | 22.99M | 16.73M | 13.20M | 4.44M | 9.23M | 7.93M |
| Total Debt | 358.00K | 117.00K | 2.92M | 6.68M | 7.46M | 3.11M |
| Total Liabilities | 26.76M | 18.64M | 22.20M | 21.43M | 22.42M | 15.20M |
| Stockholders Equity | 82.76M | 71.91M | 60.44M | 47.57M | 49.13M | 46.85M |
Cash Flow | ||||||
| Free Cash Flow | -2.83M | 6.26M | 12.59M | 538.00K | 3.64M | 4.49M |
| Operating Cash Flow | 8.10M | 12.96M | 16.94M | 3.99M | 5.56M | 6.38M |
| Investing Cash Flow | -5.61M | -6.68M | -4.41M | -4.03M | -7.14M | -1.89M |
| Financing Cash Flow | -65.00K | -2.75M | -3.78M | -4.75M | 2.88M | -405.00K |
Lifeway Foods Technical Analysis
Lifeway Foods Risk Analysis
Lifeway Foods Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $397.85M | 28.02 | 9.52% | ― | 6.62% | -7.85% | |
76 Outperform | $541.91M | 114.03 | 12.82% | ― | 29.92% | 30.02% | |
71 Outperform | $352.09M | 31.89 | 14.46% | ― | 12.14% | -17.80% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $373.48M | 22.95 | 3.20% | ― | 5.88% | -68.62% | |
49 Neutral | $447.33M | -4.74 | -27.64% | ― | 28.89% | -13.96% | |
44 Neutral | $305.70M | -8.75 | -35.78% | ― | -3.42% | -85.49% |
Lifeway Foods Corporate Events
Lifeway Foods has issued a statement addressing the nomination of dissident directors Edward Smolyansky and George Sent, citing their disqualifying track records and ethical concerns. The company highlights the dissidents’ financial distress and questionable motives, which may not align with shareholder interests. Institutional Shareholder Services has advised against supporting the dissident nominees, emphasizing Lifeway’s strong financial performance and shareholder returns. The company remains committed to board refreshment with a focus on independence and effectiveness.
On September 30, 2025, Lifeway Foods entered into a Cooperation Agreement with Danone North America, leading to the disclosure of financial projections initially shared during a due diligence process. These projections, covering the years 2025 to 2029, were not intended for public release but were disclosed to provide transparency to stakeholders. Lifeway Foods also reported record financial results for Q3 2025, with net sales reaching $57.1 million, marking a 29% increase on a comparable basis. The company achieved significant gross margin expansion and net income growth, driven by strong consumer demand for its kefir products and strategic expansions, such as the Waukesha plant. Lifeway continues to innovate with new product offerings like Muscle Mates™ and partnerships to enhance kefir visibility, positioning itself to capitalize on health trends and sustain growth.
On October 29, 2025, Lifeway Foods‘ Board approved an amendment to its Second Amended and Restated Bylaws, allowing for a Board size ranging from five to ten directors. The Board has currently set the number of directors at eight, indicating a strategic decision to potentially accommodate future growth or changes in governance.
On October 29, 2025, Lifeway Foods, Inc. announced an extension of its Shareholder Rights Agreement by one year, now expiring on October 29, 2026. The decision was made to protect against potential acquisition of control by shareholders without paying a premium, given the company’s concentrated share ownership and the potential for a substantial number of shares to become available for sale. This move aims to ensure that all shareholders can realize the full value of their investment and safeguard against control tactics without fair compensation.
Lifeway Foods, Inc. announced that its 2025 annual meeting of shareholders is scheduled for December 16, 2025. Shareholder proposals or nominations must be submitted by October 20, 2025, adhering to the company’s by-laws and Rule 14a-8 requirements.
On October 1, 2025, Jody Levy resigned from her position as a director at Lifeway Foods, Inc., a company known for its production of probiotic and functional foods. Her resignation was not due to any disagreements with the company’s operations, policies, or practices.
On September 30, 2025, Lifeway Foods, Inc. announced a Cooperation Agreement with Danone North America PBC, which includes a stay of litigation related to a Stockholders’ Agreement and plans for a board refreshment. The agreement outlines governance changes, including the appointment of independent directors and the separation of the Chair and CEO roles. Danone has agreed to support the board’s director candidates at upcoming annual meetings and to waive certain rights under the Stockholders’ Agreement. This strategic move aims to enhance corporate governance and maximize shareholder value while maintaining stability and focus on Lifeway’s core mission.
On September 18, 2025, Lifeway Foods announced that Danone has withdrawn its proposal to acquire the company. Lifeway remains focused on executing its strategic plan to enhance shareholder value, having formed a Strategic Review Committee to oversee opportunities. The company reported record-breaking sales in Q1 and Q2 2025, with continued growth into Q3, highlighting its strong market position and consistent performance.